BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 24, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Oct. 27, 2014
View Archived Issues
Kinetic analysis of the new PET ligand [11C]Lu-AE-92686
Read More
ProteoTech given FDA orphan drug status for AL amyloidosis candidate
Read More
RetroSense Therapeutics gene therapy gains FDA orphan drug status for retinitis pigmentosa
Read More
RadioMedix and Viewpoint Molecular Targeting receive grant for melanoma theranostics
Read More
iBio expands collaboration with Novici Biotech
Read More
Bavarian Nordic expands collaboration with Janssen on MVA-BN
Read More
GlaxoSmithKline reviews pipeline progress of third quarter 2014
Read More
VSV-ZEBOV Ebola vaccine candidate begins phase I study at NIAID
Read More
Serum bilirubin: a prognostic marker in primary sclerosing cholangitis
Read More
Phase III data from GEMINI trials presented for vedolizumab
Read More
First-in-human results presented for radiolabeled antibody [68Ga]ABY-025
Read More
Vitae Pharmaceuticals reports phase I results for BI-1181181/VTP-37948
Read More
The Walter Reed Army Institute discloses new agents for malaria
Read More
Novel GPR120 modulators divulged by Bristol-Myers Squibb
Read More
SHIELD 4 phase III data presented for vercirnon in patients with Crohn's disease
Read More
Sutro Biopharma and Celgene expand agreement for ADCs in immuno-oncology
Read More
U.S. group designs novel agents for depression and Parkinson's disease
Read More
Sumitomo Dainippon Pharma discloses novel RIO kinase 2 inhibitors
Read More
Bristol-Myers Squibb prepares novel agents for HIV infection
Read More
Stellar Biotechnologies agrees to supply KLH for BiovaxID
Read More
CTI BioPharma acquires worldwide rights to phase II cancer agent tosedostat
Read More
FDA sends CRL to Lundbeck regarding intravenous carbamazepine NDA
Read More
FDA approves Baxter's Obizur for acquired hemophilia A
Read More
CHMP adopts positive opinion for oxycodone/naloxone in RLS
Read More
CHMP recommends expanding approval of enzalutamide
Read More
EMA committee backs approval of olaparib in BRCA-mutated ovarian cancer
Read More
EMA recommends that Clinuvel's Scenesse be approved for EPP
Read More